Van Cutsem, E., Martinelli, E., Cascinu, S., Sobrero, A., Banzi, M., Seitz, J., Barone, C., Ychou, M., Peeters, M., Brenner, B., Hofheinz, R. D., Maiello, E., André, T., Spallanzani, A., Garcia‐Carbonero, R., Arriaga, Y. E., Verma, U., Grothey, A., Kappeler, C., Miriyala, A., Kalmus, J., Falcone, A., & Zaniboni, A. (2019). regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐Arm, Open‐Label Phase IIIb CONSIGN Study. Oncologist, 24, 185–192. http://access.bl.uk/ark:/81055/vdc_100077484632.0x000035